@seahorse_anton Dr Anton_Invests

Dr Anton_Invests posts on X about bearish, stocks, dr, $prme the most. They currently have [---] followers and [---] posts still getting attention that total [-----] engagements in the last [--] hours.

Engagements: [-----] #

[--] Week [------] +3.30%
[--] Month [-------] +48%

Mentions: [--] #

[--] Week [--] -7.60%
[--] Month [---] -10%

Followers: [---] #

[--] Week [---] +6%
[--] Month [---] +95%

CreatorRank: [-------] #

Social Influence

Social category influence stocks 62.73% finance 52.73% technology brands 18.18% cryptocurrencies 16.36% exchanges #5551 social networks 1.82% automotive brands 0.91% celebrities 0.91%

Social topic influence bearish #201, stocks 13.64%, dr #5258, $prme #36, ai 10%, bullish #1660, breakout #980, strong 8.18%, company 8.18%, $btc #1661

Top accounts mentioned or mentioned by @lexliberty76 @cletusclapton @ttrading @andresacostae @ttrading__ @acethebulllly @geneinvesting @drtomslens @michaeljburry @terrenz1972 @tjmeehan1 @epboston @theraymyers @thegaboeth @panchmukhi108

Top assets mentioned Prime Medicine, Inc. (PRME) Bitcoin (BTC) ImmunityBio, Inc. Common Stock (IBRX) Ethereum (ETH) Nebius Group N.V. Class A Ordinary Shares (NBIS) Recursion Pharmaceuticals, Inc. (RXRX) AbCellera Biologics Inc. (ABCL) Grab Holdings Limited Class A Ordinary Shares (GRAB) BTCS Inc. (BTCS) Alphabet Inc Class A (GOOGL) Hims & Hers Health, Inc. (HIMS) Oscar Health, Inc. (OSCR) Snap, Inc. (SNAP) Novo-Nordisk (NVO) Microsoft Corp. (MSFT) SBET (SBET) Bit Digital, Inc. (BTBT) BITMINE IMMERSION TECH (BMNR) NVIDIA Corp. (NVDA) Metadium (META) Robinhood Markets, Inc. (HOOD) Iris Energy Limited (IREN) Quantum Computing Inc. (QUBT) Amazon.com, Inc. (AMZN) Coupang, Inc. (CPNG) Palantir Technologies Inc. (PLTR) Super Micro Computer, Inc. Common Stock (SMCI) ZetaChain (ZETA) IonQ, Inc. (IONQ) Rigetti Computing, Inc. Common Stock (RGTI) D-Wave Quantum Inc. (QBTS) Oracle Corporation (ORCL) Mario Coin (COIN) Salesforce Inc (CRM) Adobe, Inc. (ADBE) Reddit, Inc. (RDDT) Pinterest, Inc. (PINS)

Top Social Posts

Top posts by engagements in the last [--] hours

"🧵🙇♂ Deep Dive $ABCL (AbCellera) vs $RXRX (Recursion) - Biotechs Data War Antibodies vs Algorithms The Diverging Roads of AI-Driven Biotech In the new era where biology meets computation two companies stand at the crossroads of innovation AbCellera (ABCL) and Recursion Pharmaceuticals (RXRX). Both were born from the same scientific ambition: to industrialize drug discovery using data automation and machine intelligence. Yet their paths could not be more different. AbCellera has mastered the art of antibody discovery combining microfluidics and machine learning to find therapeutic needles in"
X Link 2025-11-19T19:00Z [---] followers, [----] engagements

"Upcoming after the market close 👀 Multi-timeframe TA + quant check on [--] NASDAQ non-US names: $GRAB $NU $CPNG Want some geopolitical diversification beyond US-only exposure Youll like this thread"
X Link 2026-02-09T19:43Z [---] followers, [---] engagements

"My Take on Novovax . I dont provide HOPIUM. $NVAX is not a comeback story. Its a case study in how to vaporize shareholder value while calling it strategic. Lets talk about the part BULLS dont want to mention: The share count: 2019: 24M shares 2026: 160M+ shares Thats nearly 7x dilution. The stock didnt just fall from $320 to $8. The ownership got shredded. Even if Novavax magically returned to its [----] market cap the price wouldnt sniff those highs again. The pie is now cut into way more slices. While Pfizer $PFE and Moderna $MRNA were printing billions during peak pandemic demand $NVAX was"
X Link 2026-02-13T11:56Z [---] followers, [---] engagements

"Benzinga just dropped the updated Short Interest for $IBRX: 135.16M shares sold short. 🚨 This is a massive shift. Im about to release my 3rd Quant for $IBRX. 📊 Important: Each quant remains valid for a 2-week window (barring major black swan news). The last two played out with surgical precision. The technical setup combined with this level of short pressure is rare. I myself is a bit puzzled. May be within a week the volume is pretty stable"
X Link 2026-02-13T19:49Z [---] followers, [----] engagements

"The "Screaming" Paradox. 📉🗣 The finance world is losing its mind because Michael Burry released a 10000-word "Big Short" essay calling $PLTR the "Emperor without clothes" putting a $46 fair value on a "military stock" priced for perfection at $120+. The $PLTR cult is screaming at the top of their lungs about "unfair shorting." Yet where is the noise for $IBRX While people defend an overvalued AI giant they stay dead silent about the massive coordinated attack on $IBRX a company literally fighting to cure cancer with ANKTIVA (whatever it is why not we are seeking/ improving / transferring"
X Link 2026-02-14T22:01Z [---] followers, [----] engagements

"@acethebulllly Nice to see all in one fig.trend spider weekly daily [--] hrs. I should create such one"
X Link 2026-02-15T10:08Z [---] followers, [--] engagements

"My Take $PRCT Bullish structure is real timing is early. The falling wedge breakout is valid and momentum is constructive but volume + 4H confirmation are still weak. This looks like a post-breakout digestion not a failed move yet its not an aggressive entry zone unless 4H strength improves. 🔍 Why this matters ✅ Whats working Falling Wedge Confirmed Breakout (high-quality bullish reversal pattern) MACD (Daily & 4H): Bullish RSI (61): Healthy not overbought Price holding above former wedge resistance These are structural positives the market accepted higher prices. ⚠ Whats missing ML Breakout"
X Link 2025-12-14T21:28Z [---] followers, [---] engagements

"🧵 [----] Recap Where We Stand $MARA vs $RIOT Weekly Ichimoku + Relative Stock Value Trend & Structure $MARA (Marathon Digital Holdings): Clear trend breakdown. Lost Kijun + cloud bearish continuation $RIOT (Riot Platforms): Corrective consolidation. Weaker but closer to long-term equilibrium Ichimoku Signals MARA: Bearish Tenkan/Kijun cross both sloping down downside momentum dominant RIOT: Tenkan below Kijun but flattening selling pressure slowing Cloud & Momentum MARA: Thick bearish cloud overhead rallies are supply-driven RIOT: Thinner flatter cloud ahead potential stabilization zone Chikou"
X Link 2026-01-01T21:44Z [---] followers, [---] engagements

"4. Competitive Landscape BioNTech is a leader in multiple advanced technology fields but it faces significant competition across its core focus areas: mRNA Technology Oncology (Immunotherapies Bispecific Antibodies ADCs) and Infectious Diseases. Here are BioNTechs main competitors grouped by the technology they are rivaling: a) mRNA Technology Competitors This is the most direct area of competition extending beyond the prophylactic vaccines that brought the technology to global prominence. Note: BioNTech is in the process of acquiring CureVac. Public Exchange Offer Commenced (as of October"
X Link 2026-01-02T16:01Z [---] followers, [--] engagements

"🚨 Biotech Investing is Dangerous Too. Its not just crypto. Its not just meme stocks. Biotech can wreck your capital silently while you wait for a "miracle." Here is the cold hard truth of the market: 📉 $TXG 10x Genomics In [----] this was the "future of biology" trading at an all-time high of $202. Today (Jan 2026): It sits at $19.90. The Damage: A 90% wipeout from the peak. The Math: Your $10000 investment in [----] is now worth $985. The Lesson: $TXG is actually a leader in spatial biology with $600M+ in annual revenue but it doesn't matter. The market priced it for "infinite growth" and when"
X Link 2026-01-08T09:49Z [---] followers, [---] engagements

"📖 Reading more on $SDGR the company operates across two core segments: [--] Software Physics-based computational platform used by pharma companies and academic institutions to accelerate drug discovery. [--] Drug Discovery Internal pipeline spanning preclinical and clinical-stage programs. 🧠 Clear hybrid model: platform + pipeline. Will prepare a deep dive next. https://twitter.com/i/web/status/2011549112014160329 https://twitter.com/i/web/status/2011549112014160329"
X Link 2026-01-14T21:20Z [---] followers, [---] engagements

"Recursion Pharmaceuticals $RXRX Weekly Technical Analysis Timeframe Weekly (1W) Indicators: EMA [--] / [---] / [---] Ichimoku Cloud Volume Trend Structure (Big Picture) RXRX remains in a primary downtrend on the weekly timeframe. EMA alignment (bearish): EMA [--] (white): [----] EMA [---] (yellow): [----] EMA [---] (violet): [----] This is a textbook bearish stack: EMA50 EMA100 EMA200 Price (4.67) is below all three EMAs confirming: Long-term trend = DOWN Any bounce is counter-trend unless EMAs are reclaimed. Price Action Context RXRX has been range-bound between [----] and [----] for months. Recent candles show"
X Link 2026-01-17T10:51Z [---] followers, [---] engagements

"📊 4h TA/ML Update: $ETH treasury Stocks $BTCS $BTBT $SBET $BMNR BTCS: Neutral momentum (Strength -7) Vol Medium (45/100). Up Breakout Prob: 27% @ Res [----]. Candle: Bearish BTBT: Bullish momentum (Strength 16) Vol Medium (49/100). Up Breakout Prob: 48% @ Res [----]. Candle: Bearish SBET: Bullish momentum (Strength 12) Vol Medium (44/100). Up Breakout Prob: 70% @ Res [-----]. Candle: Bullish BMNR: Neutral momentum (Strength -1) Vol Medium (47/100). Up Breakout Prob: 33% @ Res [-----]. Candle: Bullish Overall: Cautious. Patterns & regimes signal potential breakouts amid vol spikes."
X Link 2026-01-17T22:23Z [---] followers, [---] engagements

"$LASE Laser Photonics. There are some early signs for the stock to move. Printed green candles last few days. For me it needs some more time. Who knows This field of photonics (though it is the basics of physics) is moving along with news/tweets/events on war For the first Figure: Daily close price - Top Panel: Current price ($2.58) is above Resistance ($2.57) and above Support ($2.06) with a neutral Ichimoku Cloud predicting a 35.5% chance of breaking out UP in [--] days - Not bad NEUTRAL I guess - Second Panel: MA50 slope is -0.47% with Bollinger Bands showing a range of $1.88 to $2.68 and"
X Link 2026-01-25T12:48Z [---] followers, [---] engagements

"4hrs from [--] months - I am not in critical minerals /copper. Just curious and looked into it. Though overbought these guys are kind of hot. My pick $IE & $TMQ Money flow in NAK (ie. CMF is Bearish) $IE $NAK $TMQ"
X Link 2026-01-25T22:15Z [---] followers, [---] engagements

"🧬 $IBRX ImmunityBio Update: Material Amendment to $505M Insider Debt ImmunityBio ($IBRX) filed an 8-K this morning (Jan [--] 2026) regarding an amendment to its massive $505 million convertible promissory note held by Nant Capital (Executive Chairman Dr. Patrick Soon-Shiong). 🔹 The Change: Strategic "Surgical" Flexibility Previously the debt was structured as an "all-or-nothing" conversion. The amendment signed January [--] now allows the holder to convert any portion of the $505M principal into common stock at any time before maturity. 🔹 The Math: Dilution & Conversion Price * Conversion"
X Link 2026-01-26T15:43Z [---] followers, [----] engagements

"Quick reminder: $PRME deep dive is already out. Will revisit with a proper update in March [--] once new developments are on the table. 🧵Dive Deep 🙇♂: Prime Medicine $PRME The Next Generation of Gene Editing - Part [--] [--]. 🧬 The Prime Medicine Story: Search and Replace Prime Medicine is at the forefront of the gene editing revolution founded on a breakthrough technology designed to correct the genetic causes https://t.co/jCOPt2JD6T 🧵Dive Deep 🙇♂: Prime Medicine $PRME The Next Generation of Gene Editing - Part [--] [--]. 🧬 The Prime Medicine Story: Search and Replace Prime Medicine is at the"
X Link 2026-01-29T22:02Z [---] followers, [---] engagements

"I own $GOOGL $NVDA . I prefer to invest in $NVDA now. If you invested in Jan [----] in one of MAG7 stocks you have this now (Total return + Max Drawdown). 👇 My reason to avoid $META justified - too expensive. Especially helpful for guys who allot large sums on year start"
X Link 2026-01-31T12:31Z [---] followers, [---] engagements

"If price drops further [--] to 20% I will add or modify with the following $HIMS $DLO $ZETA $OSCR (10 to 25$ stocks) . % game allocation and sell cc. Many options r there . Also $ONDS . Smell the market and slowly add $HOOD $SMCI $IREN . Personal preference. Do Ur own research . https://twitter.com/i/web/status/2018260637550326079 https://twitter.com/i/web/status/2018260637550326079"
X Link 2026-02-02T09:50Z [---] followers, [---] engagements

"$IBRX launches Chemotherapy free Phase [--] clinical study in patients with indolent B-cell non-Hodgkin lymphoma (iNHL) including Waldenstrms Macroglobulinemia"
X Link 2026-02-02T15:50Z [---] followers, [----] engagements

"$ETH treasury stocks Daily - Brief Look $BMNR $BTBT $SBET $BTCS Still all are in downtrend. All depends in $ETH price $BMNR Close: $22.80 Support: $22.58 Resistance: $29.02 RSI: [----] MACD: [-----] Stochastic: [---] ML Breakout Up (5 days): 20% 🟢 Cloud: Bearish Trend: Downtrend Vol Regime: High $SBET Close: $7.79 Support: $7.71 Resistance: $9.83 RSI: [----] MACD: [-----] Stochastic: [---] ML Breakout Up (5 days): 14% 🟢 Cloud: Bearish Trend: Downtrend Vol Regime: High $BTBT (Daily) 📈 Close: $1.94 Support: $1.92 Resistance: $2.25 RSI: [----] MACD: [-----] Stochastic: [---] ML Breakout Up (5 days): 17% 🟢"
X Link 2026-02-03T09:18Z [---] followers, [---] engagements

"Quantum Stocks Daily Brief Look- All still downtrend - CMF indicates strong selling pressure. $IONQ $RGTI $QUBT $QBTS $IONQ 🐬 SeaHorse Signal for IONQ (Daily) 📈 Close: $38.56 Support: $37.72 Resistance: $51.53 RSI: [----] MACD: [-----] Stochastic: [---] ML Breakout Up (5 days): 22% 🟢 Cloud: Bearish Trend: Downtrend Vol Regime: High $RGTI 🐬 SeaHorse Signal for RGTI (Daily) 📈 Close: $17.71 Support: $17.23 Resistance: $25.17 RSI: [----] MACD: [-----] Stochastic: [---] ML Breakout Up (5 days): 14% 🟢 Cloud: Bearish Trend: Downtrend Vol Regime: High $QUBT 🐬 SeaHorse Signal for QUBT (Daily) 📈 Close:"
X Link 2026-02-03T10:19Z [---] followers, [---] engagements

"Totally fair take and I respect the honesty about how you learn. Conviction and time horizon matter a lot most people dont even have those. I get your point: if this is part of your process and youre sized for it the lesson - good or bad - will compound either way. My suggestion just comes from looking price and focusing too much on volume all the time. Got it. [--] years horizon is really huge in current market. Respect. All good. 🤝"
X Link 2026-02-04T17:59Z [---] followers, [--] engagements

"$SNAP Q4 Earnings: The Profitable Pivot vs. The User Plateau Snap Inc. just released its Q4 [----] results. The stock is reacting with a +4% pop in after-hours trading but don't let the green candle fool youthis report is a tale of two companies. Evan Spiegel is finally choosing profit over vanity metrics. Here is the deep dive into the Snap turnaround. 👇 1/ The Financials: Efficiency is the New Vibe 💰 For the first time in a long time Snap is acting like a mature business. They beat on the bottom line while slightly edging out revenue. Revenue: $1.72B (+10% YoY) Slight beat. EPS (Adjusted):"
X Link 2026-02-04T21:48Z [---] followers, [----] engagements

"$ASST has nothing to do $BTC . No correlation wth BTC movement. Building treasury does not mean it move along with BTC. Just the crowd trying to cheat you. PUMP and DUMP guys They say dont meet your heroes but have you tried correlating your penny stocks to Bitcoin 📉🤡 I spent way too much time studying these BTC Treasuries $GPUS $NAKA $ASST so you don't have to. Spoiler: The correlation is about as strong as my New Year's resolution to stop https://t.co/V62IpAWrEF They say dont meet your heroes but have you tried correlating your penny stocks to Bitcoin 📉🤡 I spent way too much time"
X Link 2026-02-05T11:27Z [---] followers, [---] engagements

"$AMZN Q4 Pre Earnings: The Retail Giant Meets the AI Reality Check - What to Expect and Checklist Amazon reports Q4 [----] results today. After Alphabets $GOOGL massive Cloud growth and Capex warnings yesterday the stakes for Andy Jassy couldnt be higher. Amazon is expected to hit a historic milestone$700 Billion in annual revenuebut the market isn't looking at the top line. They are looking at the "hidden" margins. Here is the deep dive into what to watch. 👇 1/ AWS: Can the "Crown Jewel" Keep Up AWS has been re-accelerating hitting 20% growth in Q3. But with Google Cloud just reporting a"
X Link 2026-02-05T18:38Z [---] followers, [---] engagements

"@CletusClapton Look at the chart- This is normalised price development- nothing to do with the product or what they r going to do. In Other words if u place [---] in each one on Jan [--]. [----]. In fact $QUBT is the lowest performer"
X Link 2026-02-06T22:29Z [---] followers, [--] engagements

"To promote HIMS All [--] ca do that. A company spent years to invent a drug and pass the regulatory hurdles to sell a product. Then you make similar chemicals to sell it for cheaper. I have both $NVO (invest- swing- long association) and $HIMS ( bought for [--] yday). HIMS is going to kill their name because of this move https://twitter.com/i/web/status/2020244251192209676 https://twitter.com/i/web/status/2020244251192209676"
X Link 2026-02-07T21:12Z [---] followers, [---] engagements

"@GeneInvesting really comedy. There will be hell a lot of law suits from $NVO . HIMS now temporarily halted the sale. But still the quick reaction from FDA and Govt. is sufficient. This big accounts just offer nothing just married to some stocks and not changing their position"
X Link 2026-02-07T22:10Z [---] followers, [---] engagements

"$HIMS vs $NVO this fight isnt going to end well. Ive been a long-time $NVO shareholder. Also traded it on swings over the years historically very predictable once it dips below $50. Yesterday I picked up [--] shares of $HIMS at [--]. Not conviction curiosity. Market research. I want to see how this story unfolds and how price reacts. Reminder: never marry a stock. At the end of the day your family and real friends are all you have. Stocks wont give retail a seat in the boardroom. Period. Expand your knowledge. Ignore FURUs. Focus on the numbers. Make money."
X Link 2026-02-07T22:17Z [---] followers, [---] engagements

"$ETH treasury stocks Daily - Brief Look $BMNR $BTBT $SBET $BTCS Still all are in downtrend. All depends on $ETH price on Monday $BMNR Close: $20.47 Support: $17.19 Resistance: $29.02 RSI: [----] MACD: [-----] Stochastic: [----] ML Breakout Up (5 days): 22% 🟢 Cloud: Bearish Trend: Neutral Vol Regime: High $BTBT Close: $1.80 Support: $1.49 Resistance: $2.15 RSI: [----] MACD: [-----] Stochastic: [----] ML Breakout Up (5 days): 19% 🟢 Cloud: Bearish Trend: Neutral Vol Regime: High $SBET Close: $7.03 Support: $5.98 Resistance: $9.70 RSI: [----] MACD: [-----] Stochastic: [----] ML Breakout Up (5 days): 14% 🟢"
X Link 2026-02-07T22:35Z [---] followers, [---] engagements

"Quant: 🟡 Super Micro Computer $SMCI TBM SeaHorse Score: [----] NEUTRAL ⚖ Trend: Downtrend (post-distribution / repair phase) 🔍 What the TBM model sees Profit probability: 27.2% vs Loss: 12.0% asymmetric but not dominant. Probability-weighted R/R: 2.27x upside exists but signal conviction is weak. Model accuracy: 80.0% framework is reliable signal is not. Net conviction remains flat to slightly negative. This is not a directional edge its a wait state. 📈 Technical posture (weekly) Price is below declining MA50 trend pressure remains bearish. Kijun-sen overhead acting as dynamic resistance."
X Link 2026-02-07T22:40Z [---] followers, [---] engagements

"I would not prefer to buy $ORCL currently. Always volatile - Trading ORCL is like Gambling - Betting big on AI with debt . Many Red flags. This year we could clearly see where the stock is heading. https://t.co/ruhWI9BwyJ https://t.co/ruhWI9BwyJ"
X Link 2026-02-08T12:33Z [---] followers, [---] engagements

"Upcoming Deep Dive⚡Tomorrow : The $IREN AI Cloud Odyssey: From "Lucky Miner" to Global Power King 👑 Covering. *History *Energy infrastructure *Competition *Stock structure *Financial performance *Risks milestones and challenges https://twitter.com/i/web/status/2020594975679881285 https://twitter.com/i/web/status/2020594975679881285"
X Link 2026-02-08T20:25Z [---] followers, [---] engagements

"$NBIS Weekly Ichimoku + EMA Analysis (Feb [--] 2026) 👇 (W) $NBIS consolidating after a strong [----] run holding above key trend supports but struggling to regain momentum above the mid-$90s. Price: $86.10 (+1.1%) Tenkan (red): [----] Kijun (blue): [----] Cloud (Senkou A/B): [----] / [----] bullish base EMAs: 50: [----] 100: [----] 200: [----] ☁ Ichimoku Context Price above Cloud broader trend still bullish. Price Tenkan short-term momentum weak. Kijun below price medium-term structure intact. Future Cloud green bullish bias but flattening. Chikou Span near price confirmation mixed. 🔮 Outlook Bullish: Reclaim"
X Link 2026-02-08T20:31Z [---] followers, [---] engagements

"🟢 Nebius Group $NBIS - Quant weekly timeframe Warning: Earnings on 02/12/2026 - My TA based on No Events TBM SeaHorse Score: +0.17 BULLISH 📈 Trend: Uptrend (early but intact) 🔍 What the TBM model is flagging This one is interesting not because of raw probability but because of asymmetry. Profit probability: 18.7% Loss probability: 1.9% Probability-weighted R/R: 9.61x (exceptionally high) Model accuracy: 93.1% (small sample but clean separation) This is not a momentum chase its a fat-right-tail setup. 📈 Technical structure (weekly) Price is above MA50 with a positive MA50 slope. Ichimoku"
X Link 2026-02-08T21:39Z [---] followers, [---] engagements

"Good morning guys Ive decided not to get involved in the $HIMS / $NVO noise anymore not worth the time. The X ecosystem can be distracting. My focus is staying positive and beating my yearly record year [--] and counting. On marrying a stock: I consistently bought $NVDA and $NVO Last year trimmed / diluted $NVO $NVDA is the only stock I never sold kept adding in my investment account Ill also hold $IBRX against Big Pharma backed by genuine conviction + research Not a FURU. No hopium. Here to learn teach adapt strategies and build real market research for myself and to help retail."
X Link 2026-02-09T07:23Z [---] followers, [----] engagements

"4Hrs (4M data) $SATL - Top Panel: Current price ($3.60) is below Resistance ($3.98) and above Support ($3.19) with a neutral Ichimoku Cloud. No Doji detected. No Momentum Bar detected. No Volatility Hole. Confirmation Score: [---] (0-100 [--] suggests bullish short-term confirmation [--] suggests caution. - Second Panel: RSI at [----] is neutral suggesting no momentum shift. - Third Panel: MACD at [-----] with histogram [-----] indicates bearish momentum. - Fourth Panel: VPT and CMF at [------] indicates strong selling pressure. No clear divergence"
X Link 2026-02-09T08:12Z [---] followers, [---] engagements

"Closer Look - [--] Months of Daily Candles $SATL This 6-month view of the SATL Quant Strategic Terminal shows a significant shift from a deep accumulation phase into a high-volatility expansion. After a period of price suppression the asset is currently testing major overhead resistance. Here is the breakdown of the technical indicators: Price Action & Volume Trend Recovery: The chart displays a massive "V-shaped" recovery starting around November/December. Price has successfully reclaimed the primary support line (magenta) and recently spiked above the upper resistance channel (cyan). Recent"
X Link 2026-02-09T08:12Z [---] followers, [---] engagements

"Closer Look Daily In the $ZETA Quant Strategic Terminal (6-month daily view) the asset has undergone a sharp trend reversal following a peak that tested the Upper Resistance (cyan line). As of February [--] [----] the market is currently in a high-volatility de-risking phase. Price Action & Volume Profile Vertical Rejection: After reaching a multi-month high that breached the cyan resistance line the price experienced a massive "stop-run" or rejection leading to a swift move back toward the Primary Support (magenta line). Support Test: The price is currently hovering just above the magenta support"
X Link 2026-02-09T08:44Z [---] followers, [---] engagements

"I reiterate. Lately $ORCL became news driven Pump and Dump stock.Expect big volatility allways with ORCL 🚨ORACLE SHARES SURGE 10% WITH BUY RERATING $ORCL climbed 10% today reflecting strong market confidence in the companys financial & growth outlook. D.A. Davidson upgraded its rating to Buy from Neutral while maintaining its $180 price target on the stock. https://t.co/ZXkYwWjDcL 🚨ORACLE SHARES SURGE 10% WITH BUY RERATING $ORCL climbed 10% today reflecting strong market confidence in the companys financial & growth outlook. D.A. Davidson upgraded its rating to Buy from Neutral while"
X Link 2026-02-09T19:06Z [---] followers, [---] engagements

"$IBRX Fam. Some valuation work points to higher forward P/E leads to lower $IBRX price soon. Knabble (Toggle AI / Reflexivity) ran risk-adjusted + OOS backtests (target vs actual). I get the point. Give me [--] days Ill rerun the models same methods my features. Meanwhile $IBRX +10% today pushing toward [--] 🚀 . Can not stop the run"
X Link 2026-02-09T20:12Z [---] followers, [----] engagements

"$GRAB Multi timeframe analysis Daily close based - [--] Years - Top Panel: Current price ($18.54) is below Resistance ($19.93) and above Support ($16.74) with a bearish Ichimoku Cloud predicting a 35.5% chance of breaking out UP in [--] days. - Second Panel: MA50 slope is -0.80% with Bollinger Bands showing a range of $17.51 to $22.49 and Ichimoku lines indicating a potential downtrend. - Third Panel: RSI at [----] is neutral suggesting no momentum shift. - Fourth Panel: MACD at [-----] with histogram [-----] indicates bearish momentum. - Fifth Panel: ADX at [----] with DI+ [----] and DI- [----] shows a strong"
X Link 2026-02-10T13:07Z [---] followers, [---] engagements

"4Hrs $GRAB - Top Panel: Current price ($4.26) is above Resistance ($4.11) and above Support ($4.06) with a bearish Ichimoku Cloud. No Doji detected. No Momentum Bar detected. No Volatility Hole. Confirmation Score: [---] (0-100 [--] suggests bullish short-term confirmation [--] suggests caution. - Second Panel: RSI at [----] is neutral suggesting no momentum shift. - Third Panel: MACD at [-----] with histogram [----] indicates bearish momentum. - Fourth Panel: VPT and CMF at [------] indicates neutral pressure. No clear divergence. https://twitter.com/i/web/status/2021209456407650808"
X Link 2026-02-10T13:07Z [---] followers, [---] engagements

"Closer look - Daily Candles $GRAB Currently in a high-risk downward-trending environment. Current Price Action & Key Levels Current Price: Approximately $4.27. Medium-Term Support: The major floor (magenta line) is identified at $3.47. Immediate Support: Near-term buying interest is currently clustered at $4.19. Resistance Ceiling: The upper boundary (cyan line) sits at $5.27. Momentum & Indicator Analysis Trend Status: GRAB is currently in a falling trend channel indicating sustained selling pressure and decreasing buyer interest. Volatility: The system status is "PENDING VOLATILITY:"
X Link 2026-02-10T13:07Z [---] followers, [---] engagements

"My biggest profit last year came from $OSCR . [--] large position . Holding max few months. Accumulated DCA at [----] and sold [----] . Today in [----] bought it again at [----] . Will DCA from here. Somehow feeling good"
X Link 2026-02-10T17:06Z [---] followers, [---] engagements

"Traders Dilemma: 40% Gains vs. 300% Regret 1/ Chasing the dragon on $QNCK today. The ticker went absolutely nuclear. 🚀 2/ The reality check: If I had just held overnight Id be sitting on a 300% runner. Instead I spent the day "chopping"fighting for every tick staring at the 1-minute candles until my eyes burned. 3/ The scorecard: [--] trades total. [--] wins / [--] losses. +40% total profit. 4/ switched from "Swing" to "Machine Chopping" it feels like a battle. 5/ That transition is where the stress lives. Moving from a high-conviction hold to a frantic scalper is a psychological tax. My P&L is green"
X Link 2026-02-10T21:23Z [---] followers, [---] engagements

"Institutional Quant Alert: The Crypto "Washout" of Feb [----] 📉🤖 Bitcoin Ethereum and Solana are trapped in a high-volatility "distribution phase." While retail panics the AI models are flagging neutral momentummeaning we're likely hunting for a bottom not a breakdown. [--] Bitcoin $BTC The $70k Battleground Price Action: Rebounding toward $70000 after hitting a 15-month low last week. The Gap: Chasing a massive unfilled CME gap between $79k and $85k. Quant View: AI Model Probability is overwhelmingly Neutral (Grey bar). Levels: TP at $77226 SL at $62353. [--] Ethereum $ETH The V-Shaped Hope Price"
X Link 2026-02-10T22:56Z [---] followers, [---] engagements

"$DOGE Daily [--] Hr and Dashboard 📊 SeaHorse Panel Results (Daily): - Top Panel: Current price ($0.09) is below Resistance ($0.11) and above Support ($0.08) with a bearish Ichimoku Cloud. Trend is Neutral. No high volume breakout. - Second Panel: Bollinger Bands show price within band. MA50 at $0.12 and MA200 at $0.18 with price below MA50. Tenkan-sen ($0.10) is below Kijun-sen ($0.11). - Third Panel: RSI at [----] is oversold suggesting a possible reversal. - Fourth Panel: MACD at [-----] with histogram [-----] indicates bearish momentum. - Fifth Panel: ADX at [----] with DI+ [---] and DI- [----] shows a"
X Link 2026-02-11T07:21Z [---] followers, [---] engagements

"$COIN Daily Panels: - Top Panel: Current price ($162.51) is below Resistance ($203.67) and above Support ($145.16) with a bearish Ichimoku Cloud predicting a 35.5% chance of breaking out UP in [--] days. - Second Panel: MA50 slope is -0.87% with Bollinger Bands showing a range of $141.79 to $267.06 and Ichimoku lines indicating a potential downtrend. - Third Panel: RSI at [----] is oversold suggesting a possible reversal. - Fourth Panel: MACD at [------] with histogram [-----] indicates bearish momentum. - Fifth Panel: ADX at [----] with DI+ [---] and DI- [----] shows a strong trend with downward bias. -"
X Link 2026-02-11T09:25Z [---] followers, [---] engagements

"$OSCR Multi timeframe analysis 🧵 Daily Panels: -------------------------------------------------- - Falling Wedge Pattern: Detected Forming (Awaiting Breakout) - Other Reversal Pattern: No recent reversal pattern detected (N/A) - Top Panel: Current price ($12.88) is below Resistance ($14.46) and above Support ($11.85) with a bearish Ichimoku Cloud predicting a 35.5% chance of breaking out UP in [--] days. - Second Panel: MA50 slope is -0.67% with Bollinger Bands showing a range of $11.73 to $17.95 and Ichimoku lines indicating a potential downtrend. - Third Panel: RSI at [----] is neutral"
X Link 2026-02-11T09:52Z [---] followers, [---] engagements

"$OSCR 4-Hour Panels: Top Panel: Current price ($12.90) is below Resistance ($13.65) and above Support ($11.85) with a bearish Ichimoku Cloud. No Doji detected. No Momentum Bar detected. No Volatility Hole. Confirmation Score: [---] (0-100 [--] suggests bullish short-term confirmation [--] suggests caution. - Second Panel: RSI at [----] is neutral suggesting no momentum shift. - Third Panel: MACD at [-----] with histogram [----] indicates bearish momentum. - Fourth Panel: VPT & CMF at [------] indicates strong selling pressure. No clear divergence. Summary 🐬 4H Intraday Confirmation for OSCR 📈Close:"
X Link 2026-02-11T09:52Z [---] followers, [---] engagements

"Reminder - My deep dive on Moderna $MRNA #mRNA Moderna $MRNA Deep Dive 🙇♂ (Part 1): Beyond the Pandemic Peak Can mRNA Cure Cancer and Justify the 'Platform' Valuation Table of Contents Introduction Research & Core Focus Pipeline & Clinical Focus Competition (Tech Viewpoint) IPO & Fundamentals (Including Q3 Report) https://t.co/8nSDIvKG5N Moderna $MRNA Deep Dive 🙇♂ (Part 1): Beyond the Pandemic Peak Can mRNA Cure Cancer and Justify the 'Platform' Valuation Table of Contents Introduction Research & Core Focus Pipeline & Clinical Focus Competition (Tech Viewpoint) IPO & Fundamentals (Including"
X Link 2026-02-11T13:19Z [---] followers, [---] engagements

"Pre-Earnings Analysis: Nebius Group [---] FEB [----] $NBIS 1/ Company Context Important Clarification Nebius Group N.V. emerged from the restructuring of Yandexs international assets. They are positioning themselves as a European sovereign AI cloud + GPU infrastructure provider competing indirectly with: - Amazon Web Services $AMZN - Microsoft $MSFT - Google $GOOGL But their actual competitive set is closer to: CoreWeave (private) Lambda Labs IREN Crusoe Energy That distinction matters when evaluating valuation. 2/ The Numbers Sanity Check Revenue: $232M $246M If Q3 was $146M and Q4 jumps to"
X Link 2026-02-11T13:22Z [---] followers, [--] engagements

"Yes. From a systems perspective a 78% neutral (very unusual) outcome probability in a Bitcoin quant model is not just "indecision"it is a state of maximum structural compression. I think the model has reached a "bifurcation point" where previous trend data can no longer forecast the next directional move. https://twitter.com/i/web/status/2021689456265228634 https://twitter.com/i/web/status/2021689456265228634"
X Link 2026-02-11T20:55Z [---] followers, [--] engagements

"Guys I see $BTC 78% NEUTRAL outcome probability in quant model. And both BULL and BEAR are minimum. check my previous post. It is highly unusual to see this structure Perhaps Make or Break Mechanics structure from here and it is showing as NEUTRAL. Also 78% neutral rating indicates that the input variables are contradicting each other. It should cross 72K first for safe side. https://twitter.com/i/web/status/2021691381362962586 https://twitter.com/i/web/status/2021691381362962586"
X Link 2026-02-11T21:02Z [---] followers, [---] engagements

"Pre-Earnings Analysis: Nebius Group [---] FEB [----] $NBIS Pre-Earnings Analysis: Nebius Group [---] FEB [----] $NBIS 1/ Company Context Important Clarification Nebius Group N.V. emerged from the restructuring of Yandexs international assets. They are positioning themselves as a European sovereign AI cloud + GPU infrastructure provider Pre-Earnings Analysis: Nebius Group [---] FEB [----] $NBIS 1/ Company Context Important Clarification Nebius Group N.V. emerged from the restructuring of Yandexs international assets. They are positioning themselves as a European sovereign AI cloud + GPU infrastructure"
X Link 2026-02-11T21:57Z [---] followers, [---] engagements

"@DrTomsLens SaaS - The Buyback Squeeze occurs in $ADBE $CRM - people r not talking. I am not sure about the end game. It is too hard to say what is next But they r buying back - massive scale. Adobe: record pace with a $25B program. Salesforce: Added $20B to their buyback (total $50B)"
X Link 2026-02-11T22:11Z [---] followers, [---] engagements

"Fastly $FSLY reported impressive fourth-quarter [----] "crushed" analyst expectations and triggered a massive surge in the stock price during extended trading. The stock rose as much as 25% to 32% in after-hours trading reaching approximately $12.32. Earnings Triple-Threat Confirmation The "triple-threat" beat . Double Earnings Beat: Fastly reported adjusted earnings of $0.12 per share exactly doubling the analyst consensus of $0.06. Revenue Growth: Quarterly revenue reached $172.6 million exceeding the expected $161.4 million and marking a 23% year-over-year increase. Aggressive Guidance: For"
X Link 2026-02-11T22:37Z [---] followers, [---] engagements

"In the Saas carnage one thing is going on. Big stock buyback by some like ADBE and CRM . Even with AI agents enterprise infrastructure doesn't vanish overnight. Very difficult to guess now. Salesforces $5.6B Army deal and Adobe's record Q4 revenue prove that these platforms are the "connective tissue" of business. The DCF Reality: Using a standard Discounted Cash Flow model Adobe is currently trading at a 45% discount to its intrinsic value. If they maintain even 10% growth the current price is a mathematical anomaly. In the AI race new companies are financing through borrowed money and share"
X Link 2026-02-12T07:57Z [---] followers, [---] engagements

"Agree Last [--] years SAP is the only big software giant. Now no investment in AI or energy (though we run energy intensive industries) even any tech. Some just living in dreams and telling the people we are in the forefront of innovation. Some linked in suits making so many posts about it. Hard to believe"
X Link 2026-02-12T14:23Z [---] followers, [---] engagements

"🧵Multitime frame analysis + Quant Here Weekly Ichimoku + EMA breakdowns for the social media names $PINS $SNAP $RDDT 👇 My Take: Overall Sentiment: Bearish Caution 🐻Watching for volume-backed breakout attempts near resistance. 1/ $PINS Weekly Ichimoku + EMA Analysis (W) $PINS broke down hard losing major support and accelerating lower toward the $1819 area. Structure clearly bearish. Price: $18.53 (5.4%) EMA50: [----] EMA100: [----] EMA200: [----] (Price well below all major EMAs) ☁ Ichimoku Context Price far below cloud strong bearish trend Tenkan Kijun downside momentum dominant Future cloud"
X Link 2026-02-12T19:06Z [---] followers, [---] engagements

"Social Media Stocks. $PINS $RDDT $SNAP $META If you invested 100$ in each at the beginning of [----] you have this now 👇 $PINS : 60.94$ $RDDT : 78.04$ $SNAP : 42.66$ $META: 109.11$"
X Link 2026-02-12T19:21Z [---] followers, [---] engagements

"Today Nebius Group $NBIS reported Q4 and Full-Year [----] results that solidify its status as a high-growth AI infrastructure play though the "cash burn" story remains a central focus for critics. The market's reaction centers on the massive revenue beat fueled by the start of the Microsoft $MSFT and $META contracts balanced against a heavy increase in CapEx as they race to build out capacity. $NBIS Q4 [----] Earnings Comparison Table Below: Critical Analysis: The "Specialist" View [--]. The ARR "Rocket Ship" 🚀 Management didn't just meet their $900M$1.1B ARR target; they blew past it to $1.25"
X Link 2026-02-12T19:42Z [---] followers, [---] engagements

"$BTC still NEUTRAL not bad. I see no stock trading for [--] days. Will crypto move then Never Boring. we can only observe the technicals and look at the outcome Probabilities. 📊 SeaHorse Panel Results (4-Hour): - Top Panel: Current price ($69058.88) is below Resistance ($69482.97) and above Support ($65118.00) with a neutral Ichimoku Cloud. Price is above VWAP ($67363.99). Highest volume price level at $69058.88. No Momentum Bar. No Volatility Hole. - Second Panel: RSI at [----] is neutral suggesting no momentum shift. - Third Panel: Volume Z-score at [----] indicates normal trading activity. MACD"
X Link 2026-02-13T17:44Z [---] followers, [---] engagements

"@TTrading__ Ha ha. Sometimes I am like the Good Dr"
X Link 2026-02-13T19:15Z [---] followers, [--] engagements

"@TTrading__ Not a Med Dr though sometimes I am Zombi mode (like him)"
X Link 2026-02-13T19:37Z [---] followers, [--] engagements

"🧵Dive Deep 🙇♂: Prime Medicine $PRME The Next Generation of Gene Editing - Part [--] [--]. 🧬 The Prime Medicine Story: Search and Replace Prime Medicine is at the forefront of the gene editing revolution founded on a breakthrough technology designed to correct the genetic causes of disease with unprecedented precision. The Genesis of Prime Editing The companys story begins not in a boardroom but in a research lab emerging from one of the most prestigious scientific institutions in the world. Technology Origin: Prime Editing technology was developed in the lab of Dr. David R. Liu (Co-Founder and"
X Link 2025-12-27T15:40Z [---] followers, [----] engagements

"Key Founding & Early Leadership The company quickly attracted seasoned biotech veterans to lead its translation from the lab bench to the patient bedside. Scientific Founders: Dr. David R. Liu and Dr. Andrew Anzalone. Early CEO: Dr. Keith Gottesdiener served as the President and CEO during the initial launch and growth phases. Current Leadership: As of mid-2025 the leadership transitioned with Dr. Allan Reine (M.D.) becoming the Chief Executive Officer and Jeffrey Marrazzo (M.B.A. M.P.A.) taking the role of Executive Chair. Founded Year [----] Launch/Major Funding: The company officially"
X Link 2025-12-27T15:40Z [---] followers, [---] engagements

"The Main Work: Prime Editing Technology $PRME Prime Medicines entire mission is built on its proprietary Prime Editing platform a next-generation gene editing tool. Core Goal: To develop a new class of differentiated one-time curative genetic therapies to address the widest spectrum of diseases. Mechanism: Prime Editing is a search and replace gene editing technique. It uses a modified Cas9 enzyme combined with a reverse transcriptase guided by an RNA molecule to: Search for the precise location in the genome with the faulty DNA. Replace the segment of faulty DNA with a corrected copy. Key"
X Link 2025-12-27T15:40Z [---] followers, [---] engagements

"2. Main Areas of Focus $PRME Prime Medicines pipeline is currently focused on developing programs across several core therapeutic areas: Liver Diseases: E.g. Wilsons Disease Alpha-1 Antitrypsin Deficiency (AATD). Hematology Immunology & Oncology: E.g. Chronic Granulomatous Disease (CGD). Lung Diseases: Including efforts in Cystic Fibrosis (CF).Prime Medicine organises its pipeline around three core therapeutic areas: liver lung and immunology & oncology Here are key programs and statuses: https://twitter.com/i/web/status/2004940560998543819 https://twitter.com/i/web/status/2004940560998543819"
X Link 2025-12-27T15:40Z [---] followers, [---] engagements

"Targeting Liver and Lung Diseases In Vivo $PRME A major differentiator for Prime Editing is its potential for in vivo (inside the body) correction using Lipid Nanoparticles (LNP) to deliver the editor directly to the target organ. Liver Focus: Programs for Wilsons Disease and Alpha-1 Antitrypsin Deficiency (AATD) are rapidly advancing toward IND-enabling studies. These liver-targeting programs aim to fix the genetic mutation directly in the liver cells to prevent disease progression. Lung Focus: The company is also researching Prime Editors for Cystic Fibrosis (CF). This program is in the"
X Link 2025-12-27T15:40Z [---] followers, [---] engagements

"3. Key IPO to Share Structure $PRME Prime Medicines Initial Public Offering (IPO) in late [----] was one of the largest in the biotech sector that year reflecting strong investor confidence in the gene-editing technology 💰 Prime Medicine: Pre-IPO Funding and Public Listing The companys significant financial journey began with two major private funding rounds that culminated in a large IPO. Initial Private Funding (Pre-IPO) Prime Medicine raised a total of $315 million in private financing across two rounds: a Series A and a Series B. https://twitter.com/i/web/status/2004940570406306014"
X Link 2025-12-27T15:40Z [---] followers, [---] engagements

"This substantial private funding positioned the company with strong financial backing to advance its Prime Editing technology. $PRME Significant Public Listing (IPO) Prime Medicine transitioned to a publicly traded company on October [--] [----]. The IPO was considered one of the largest biotech IPOs of [----] selling approximately [----] million shares at $17.00 a piece. It followed the private funding by a little over a year demonstrating strong investor confidence in the companys gene-editing platform. As a highly-anticipated platform biotech Prime Medicine quickly moved from its initial private"
X Link 2025-12-27T15:40Z [---] followers, [---] engagements

"Top Institutional Holders of $PRME (Late 2025) Alphabet (the parent company of Google/GOOGL) is a significant investor in Prime Medicine (PRME). The relationship exists through both early-stage venture capital and current public market holdings. As of late [----] Alphabet remains one of the largest institutional shareholders of the company. Key Investment Details Initial Investment: Alphabets venture capital arm GV (formerly Google Ventures) was an early backer participating in Prime Medicines $200 million Series B funding round in July [----]. Current Stake: According to 13F filings from late"
X Link 2025-12-27T15:40Z [---] followers, [---] engagements

"4. Core strength & Direct Competition Prime Medicine $PRME is building prime editing therapies (a CRISPR-derived editor that rewrites DNA without double-strand breaks) with programs across liver (Wilsons AATD) lung (CF) and ex-vivo T-cell edits (BMS collaboration). Prime reported the first human data with a prime-edited therapy in [----] (CGD) and the Cystic Fibrosis Foundation has added follow-on funding for a CF program. A key backdrop: the CRISPR field has reached commercial reality (Vertex/CRISPR Txs CASGEVY approval for SCD/TDT) setting clinical regulatory and reimbursement goalposts for"
X Link 2025-12-27T15:40Z [---] followers, [---] engagements

"Investor Take $PRME PRMEs moat: precision editing + insertion capacity; potentially fewer off-target effects than base or Cas9 editors. Risks: unproven delivery increasing dilution (131 M shares) and a crowded gene-editing field where LNP expertise may determine winners. Catalysts: human prime-editing readouts (20252026) BMS collaboration milestones CF Foundation partnership updates and progress in extrahepatic delivery. What to watch / caveats The current revenue figure is very small (US$3 m for 2024) relative to their R&D and G&A expenses meaning they are heavily dependent on financing and"
X Link 2025-12-27T15:41Z [---] followers, [---] engagements

"5. Prime Medicine Financial Snapshot $PRME [--] Revenue vs Net Income (Chart 1) Revenues: peaked at $5 M in [----] but have since stayed minimal ($3 M in [----] $1 M LTM 2025). This reflects that PRME is still a pre-commercial R&D biotech earning mainly collaboration revenue (e.g. from BMS) not product sales. Net Income: persistently negative $184 M (2021) $198 M (2023) $199 M (LTM). Losses stem from heavy R&D investment expanding pre-clinical pipeline and high G&A tied to scaling operations. Interpretation: The widening gap between almost-flat revenue and large net loss shows that Primes value is"
X Link 2025-12-27T15:41Z [---] followers, [---] engagements

"Strategic Research & Development $PRME The company is strategically shifting its focus toward its in vivo liver franchise and deprioritizing certain other programs. Core Liver Programs: * Wilsons Disease: On track for IND and/or CTA filings in the first half of [----]. Alpha-1 Antitrypsin Deficiency (AATD): Target IND/CTA filing in the middle of [----]. Clinical Progress (PM359): Initial Phase 1/2 data for its Chronic Granulomatous Disease (CGD) candidate showed dihydrorhodamine positivity levels exceeding those believed to be potentially curative in the first two patients. Operational Changes:"
X Link 2025-12-27T15:41Z [---] followers, [---] engagements

"6. 🧩 Final Take Prime Medicine ($PRME) Prime Medicine is still in its pre-commercial stage trading more on science and future potential than on fundamentals. The company is pioneering prime editing a next-gen gene-editing technology designed to precisely rewrite DNA without double-strand breaks potentially safer and more versatile than CRISPR or base editing. Fundamentals: Early-stage biotech profile minimal revenue high R&D burn improving cost discipline after its [----] pipeline refocus. Pipeline: Focused on large-market liver diseases (Wilsons AATD) CF (with CF Foundation support) and"
X Link 2025-12-27T15:41Z [---] followers, [---] engagements

"Recap [----] $ABCL vs $RXRX Final Thoughts Relative Stock Value [----] $ABCL vs $RXRX Normalized performance (=$100 invested): If both started at $100 AbCellera Biologics ($ABCL) would be worth meaningfully more today than Recursion Pharmaceuticals ($RXRX) ABCL won the [----] performance race. Relative strength: Leadership shifted decisively to ABCL mid-year; the ratio remains elevated despite recent cooling outperformance intact momentum moderating. Dislocation & flow: ABCL saw periods of overextension but kept stronger institutional follow-through; RXRX spent more time in mean-reversion and"
X Link 2026-01-01T21:54Z [---] followers, [----] engagements

"$ABCL & $RXRX My Quant Take: ABCL RXRX for short-horizon alpha. ABCL offers direction + asymmetry. RXRX offers optional upside without edge. In the TBM framework: ABCL = probabilistic long RXRX = conditional setup awaiting confirmation 👇 🟢 AbCellera Biologics (ABCL) TBM SeaHorse Score: +0.22 BULLISH 📈 Trend: Uptrend (early expansion) What the model sees Profit probability (31.3%) vs loss (9.2%) clear positive skew. Neutral regime still dominant but directional bias is constructive. Probability-weighted R/R: 3.42x asymmetric upside. Technical posture Price holding above MA50 cloud"
X Link 2026-01-24T21:36Z [---] followers, [----] engagements

"Upcoming Deep Dive: $VRTX From a scrappy biotech to one of the most profitable pharma companies ever built. CF cash machine bold pipeline bets hard science real risks. History. Pipelines. Milestones. Fundamentals. Vertex Pharmaceuticals misunderstood again"
X Link 2026-01-31T17:23Z [---] followers, [---] engagements

"$IREN Post-Earnings Deep Dive: The Cost of Transition The market just handed $IREN a -22% verdict sending shares to $34. On the surface it looks like a disaster: a $155M net loss and a revenue slide. But if you dig into the 8-K you see a company radically de-risking its $9.7B Microsoft contract while getting punched by non-cash accounting items. Here is the breakdown of the "Checklist vs. Reality." 1/ The Checklist: Did They Deliver (Check the Table Below) The Verdict: They missed the current revenue numbers but over-delivered on the future war chest. The market is punishing the "now" while"
X Link 2026-02-05T22:21Z [---] followers, [----] engagements

"The "SaaS Carnage" of [----] has officially moved from a "bad quarter" to a total re-rating of the industry. As of February [--] [----] the data is clear: software giants aren't dyingthey are becoming Value stocks. Here is the breakdown $ADBE $CRM $SNOW $NOW https://t.co/sQjqbzIkKb https://t.co/sQjqbzIkKb"
X Link 2026-02-06T07:44Z [---] followers, [---] engagements

"If you bought quantum stocks $IONQ $RGTI $QUBT $QBTS in [----] Jan you have this Normalised price development. $QBTS outperformed"
X Link 2026-02-06T21:58Z [---] followers, [----] engagements

"🔴 Snap $SNAP TBM SeaHorse Score: [----] BEARISH Trend: Downtrend (structural weakness intact) What the TBM model sees: Profit probability: 4.0% vs Loss: 15.3% heavily skewed downside. Probability-weighted R/R: 0.26x negative expectancy. Model accuracy: 90.7% this is a high-confidence bearish read. Net conviction stays firmly negative no reflexive bounce signal.This is not noise its a statistically validated downside regime. Technical posture (weekly): Price is well below MA50 with a negative MA50 slope. Ichimoku cloud overhead and bearish trend ceiling firmly in place. Support levels failing"
X Link 2026-02-08T12:55Z [---] followers, [---] engagements

"$CPNG Daily Close Price - Strong buying pressure observed today - Suddenly emerging. - Top Panel: Current price ($18.54) is below Resistance ($19.93) and above Support ($16.74) with a bearish Ichimoku Cloud predicting a 35.5% chance of breaking out UP in [--] days. - Second Panel: MA50 slope is -0.80% with Bollinger Bands showing a range of $17.51 to $22.49 and Ichimoku lines indicating a potential downtrend. - Third Panel: RSI at [----] is neutral suggesting no momentum shift. - Fourth Panel: MACD at [-----] with histogram [-----] indicates bearish momentum. - Fifth Panel: ADX at [----] with DI+ 17.6"
X Link 2026-02-10T00:15Z [---] followers, [---] engagements

"Reminder $DUOL . $DUOL Guys I warned you more than few occasions about 120$ target and asked you to place a SL at [---]. If it breach 120$ you can get it below 100$. I lost interest because some guys just married to a stock. Look fundamentals market expectation - do not align straight line and $DUOL Guys I warned you more than few occasions about 120$ target and asked you to place a SL at [---]. If it breach 120$ you can get it below 100$. I lost interest because some guys just married to a stock. Look fundamentals market expectation - do not align straight line and"
X Link 2026-02-11T21:11Z [---] followers, [---] engagements

"$IBRX Fridays Last Hour Sell-Off Unexpected last-hour weakness on Friday following media coverage. 🔹 Two weeks ago we identified the $5.80$7.20 range 🔹 Strong consolidation inside that band 🔹 Price now sitting right at $6.00 support Volume spike into the close suggests reactive selling rather than structural breakdown. Were watching closely: $5.80 = Range low $6.00 = Psychological + technical support $7.20 = Range high / breakout trigger If $6 holds into the close range structure remains intact. If lost retest of $5.80 likely. [--] minutes left in the session. My Take: Still range-bound."
X Link 2026-02-13T20:48Z [---] followers, [----] engagements

"4h $ETH Treasury Stocks Update Date: February [--] [----] The following snapshot provides a cleaned-up overview of the 4-hour technical and machine learning (ML) data for key Ethereum-centric and Bitcoin treasury stocks. $BTCS BTCS Inc. Price: [----] (Chg: +0.9%) Trend: Neutral Ichimoku: Bearish Momentum: Bearish (Strength: -10.5/100) S/R Levels: Support: [----] Resistance: [----] ML Forecast: 15% Probability of Upward Breakout. Latest Candle: Bullish (No Hammer/Engulfing detected). $BTBT Bit Digital Inc. Price: [----] (Chg: +0.2%) Trend: Neutral Ichimoku: Bearish Momentum: Bearish (Strength: -2.0/100)"
X Link 2026-02-13T21:42Z [---] followers, [---] engagements

"🔍 $BTC Mining Stocks 4h TA/ML Snapshot The sector is showing heavy bearish momentum with Ichimoku clouds confirming a downward trend across most major miners. However money flow is improving today. Long weekend. All signals will change after this crypto only trading long weekend. Do not conclude anything now. Quick Summary: $HIVE : [----] (Neutral) Bearish (-8.5) 🐻 $CIFR : [-----] (Neutral) Neutral (+3.0) ⚖ $CLSK : [----] (Neutral) Bearish (-6.5) 🐻 $MARA : [----] (Neutral) Bearish (-4.5) 🐻 Detailed Breakdown: HIVE Digital ($HIVE) Price: [----] (Ichimoku: Bearish) Momentum: -8.5/100 (Bearish) ML"
X Link 2026-02-13T23:13Z [---] followers, [---] engagements

"@LexLiberty76 Yes Sure expect big volatility. Just puzzled by the SHORT interest"
X Link 2026-02-14T05:16Z [---] followers, [--] engagements

"Biotech is asymmetric by nature. Some investments create generational wealth. Others end in complete wipeouts. Success depends on Clinical data Regulatory approval Commercial execution Strategic collaborations Bringing in Saudi is a strong signal if capital flows from there - deep pockets + long-term horizon. That materially de-risks funding risk. High risk. High reward. I am for anything slowly moving away safely from Chemo. Many research did not translate in this field. https://twitter.com/i/web/status/2022613293601362177 https://twitter.com/i/web/status/2022613293601362177"
X Link 2026-02-14T10:06Z [---] followers, [--] engagements

"$BTC too. Unusually calm. Volume increased"
X Link 2026-02-14T13:49Z [---] followers, [---] engagements

"No indicators. Just tracking where the Price ball spent most of the time each day last week by looking each [--] min bins $HOOD Monday - [-----] Tuesday - [-----] Wednesday - [-----] Thursday - [-----] Friday - [-----] No Pattern"
X Link 2026-02-14T17:15Z [---] followers, [---] engagements

"⚡ Tesla Inc. $TSLA Quant TBM SeaHorse Score: [----] NEUTRAL ⚖ Trend: Uptrend (late-cycle phase) 🔎 TBM Summary What the model actually sees Profit probability: 8.8% Loss probability: 28.1% Neutral probability: 63.1% Probability-Weighted R/R: 0.31x (weak asymmetry) Model accuracy: 88.9%This is not bearish enough to short but its too asymmetric to chase long. TBM interpretation: uptrend exhaustion risk rising. 📈 Structure (Weekly) Price still above MA50 (trend intact structurally). However: Resistance near [------] zone repeatedly tested. Momentum no longer expanding. Cloud flattening trend"
X Link 2026-02-14T21:08Z [---] followers, [---] engagements

"Weekly TBM Quant Breakdown $ABCL vs $RXRX Note: Will run the Quant again on Sat'day . Sth interesting going on. AbCellera Biologics (ABCL) Signal: ⚖ NEUTRAL TBM SeaHorse Score: [-----] Timeframe: Weekly Horizon: [--] weeks (1.5ATR) One of highest neutrality profiles I scanned. Executive Summary: ABCL is technically alive but statistically questionable. The model sees very high neutrality low volatility edge and poor reward asymmetry. This is a wait-state asset not an alpha generator. Market Structure Price: $4.13 Trend: Nominal uptrend but weak structure MA50: Flat no directional slope advantage"
X Link 2026-01-07T22:33Z [---] followers, [---] engagements

"@LexLiberty76 A great CEO should focus on his company (research regulation product) - not tracking share price every day commenting and even taking action against"
X Link 2026-02-14T12:33Z [---] followers, [--] engagements

"This comprehensive 14-page 6600-word deep dive into IREN (formerly Iris Energy) synthesizes corporate history energy infrastructure competition stock structure and financial performance. It http://x.com/i/article/2020271766514659328 http://x.com/i/article/2020271766514659328"
X Link 2026-02-09T12:18Z [---] followers, [----] engagements

"I am really speechless - Tax on Unrealized Gains in Netherland. The Dutch government is destroying long term compounding by introducing a 36% tax on unrealized gains. As a Dutch citizen and long term investor Im at a loss for words about the lack of vision behind this new tax. I normally dont post anything politically related but what https://t.co/9HYM7l0qTc The Dutch government is destroying long term compounding by introducing a 36% tax on unrealized gains. As a Dutch citizen and long term investor Im at a loss for words about the lack of vision behind this new tax. I normally dont post"
X Link 2026-02-13T12:12Z [---] followers, [---] engagements

"@AndresAcostaE May be [--]. Next day [--] May be. Just PUMP and DUMP . For high risk takers only"
X Link 2026-02-13T22:10Z [---] followers, [---] engagements

"The $IBRX "Last Hours" Raid Forget the indicators for a second. Just look at where the $IBRX ball spent the week (Fig 1). 🎾 For [--] days we watched a gradual orderly consolidation. By Friday morning (Feb 13) the system looked primed. We were cruising in the $6.80$7.20 range and even touched $7.30. The structure was healthy. Then the Last Hours "Twist": In the final [---] minutes a surgical strike hit. The price was slammed from $7.07 to $5.94. We were puzzleduntil we looked at the data. This wasn't a "sell-off"; it was a coordinated hunt. The Weekly Recap (The Set-up): Monday: $6.47 (Support"
X Link 2026-02-14T17:45Z [---] followers, [----] engagements

"🔍 TA/ML Snapshot (4h 6mo) $COIN $HOOD $MSTR Overall Sentiment: Mixed / Cautious. Watching. All depends on Cryptomarket $BTC $ETH next week $COIN Price: [------] (Chg: 0.0%) S/R: Support [------] Resistance [------] Trend: Neutral (Ichimoku: Bearish) RSI: [----] MACD Hist: [----] (Bullish) CMF: [------] (Bearish) Momentum: Bearish (-6.5/100) Volatility: Medium (54.8) ML Breakout Prob (next [--] bars): 39% (Watch DOWN) $HOOD Price: [-----] (Chg: 0.2%) S/R: Support [-----] Resistance [-----] Trend: Neutral (Ichimoku: Bearish) RSI: [----] MACD Hist: [----] (Bullish) CMF: [------] (Bearish) Momentum: Bearish (-10.5/100)"
X Link 2026-02-15T21:00Z [---] followers, [---] engagements

"Monitoring the 4h-6M crypto stock data with high caution. 🔍 With the U.S. markets closed for Presidents' Day we are in a liquidity gap. So far $BTC ($69.0k) and $ETH ($2.0k) are tilting bearish stuck in a dominant downtrend/ starting downtrend (we will know tomorrow). The Strategy for Tuesday: Do not blindly "buy the open." If $BTC and $ETH break support levels during this holiday gap expect a violent repricing in crypto-linked equities ($COIN $MSTR $MARA and many treasury stocks) when the bell rings on Tuesday. The correlation with tech is high (+0.6 with $MARA like) but the downside"
X Link 2026-02-15T21:40Z [---] followers, [---] engagements

"@TTrading__ @michaeljburry Already all points below [---]. When that hits naturally all wait for [---]. Quant confirms the high probability for 102"
X Link 2026-02-16T11:16Z [---] followers, [--] engagements

"📉 Palantir Technologies Inc. $PLTR Quant TBM SeaHorse Score: [----] BEARISH Regime: Late-trend rollover 🔬 What The Model Is Saying (Objectively) TBM Probabilities (2-week horizon 1.5ATR) 🟢 Profit: 13.7% ⚪ Neutral: 45.0% 🔴 Loss: 41.3% ⚖ Probability-Weighted R/R: 0.33x 🎯 Model Accuracy: 82.8% This is not mild weakness. This is negative asymmetry expansion. 📊 Structural Read (Weekly) PLTR shows classic distribution behavior: Repeated rejection near resistance Price flattening while: RSI rolling lower MACD histogram turning negative Cloud narrowing trend compression OBV flattening buyer"
X Link 2026-02-15T20:13Z [---] followers, [---] engagements

"Remember Bill Gates was a very high profile investor in Beyond Meat $BYND in [----] before its IPO. He was clever to exit entire position in late [----] cashing out around the $160 / share mark. If you invested 10000$ in [----] (Stock price 160) now you have 46$ (Price 0.70) Became a 'Meme' stock - sometimes it jump from [---] to 7$ like in Oct [----]. If you invested $10000 in Beyond Meat in [----] today you would have $41. https://t.co/9oAA8uBEpb If you invested $10000 in Beyond Meat in [----] today you would have $41. https://t.co/9oAA8uBEpb"
X Link 2026-02-15T20:23Z [---] followers, [---] engagements

"Coded and trying to get weekly (3Y) Daily (1Y) 4H (6M) in one figure. Not sure readable or too many panels. Vibe. $NVDA"
X Link 2026-02-16T17:20Z [---] followers, [--] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing